Seeing Is Believing
Currently out of the existing stock ratings of Jason Gerberry, 143 are a BUY (63.27%), 56 are a HOLD (24.78%), 27 are a SELL (11.95%).
Analyst Jason Gerberry works at BAML with a stock forecast success ratio of 61.43% fulfilled within 254.62 days on average.
Jason Gerberry’s has documented 472 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GLPG, Galapagos NV ADR at 01-Apr-2024.
Analyst best performing recommendations are on CORI (CORIUM INTERNATIONAL).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $261 was fulfilled within 2 days with a profit of $32.55 (14.25%) receiving and performance score of 71.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$27.2 (16.21%)
185
29 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$21.2 (12.63%)
181
2 months 19 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$27.2 (16.21%)
180
2 months 19 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-2.8 (-1.67%)
157
3 months 8 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$12.2 (7.27%)
195
3 months 22 days ago
3/5 (60%)
$21.06 (13.25%)
496
Which stock is Jason Gerberry is most bullish on?
Which stock is Jason Gerberry is most reserved on?
What Year was the first public recommendation made by Jason Gerberry?